8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  April 30, 2014 (April 30, 2014)

AMSURG CORP.

(Exact Name of Registrant as Specified in its Charter)

Tennessee	000-22217	62-1493316
(State or Other Jurisdiction of Incorporation)	(Commission  File Number)	(I.R.S. Employer  Identification No.)
20 Burton Hills Boulevard
Nashville, Tennessee		37215
(Address of Principal Executive Offices)		(Zip Code)

(615) 665-1283

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

        Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01.   Regulation FD Disclosure

On April 30, 2014, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.

Item 9.01.   Financial Statements and Exhibits

(d)  99 Press release dated April 30, 2014

2

SIGNATURES
	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
			AMSURG CORP.
		By:	/s/ Claire M. Gulmi
			Claire M. Gulmi
			Executive Vice President and
			Chief Financial Officer
			(Principal Financial and Duly Authorized Officer)
Date:	April 30, 2014

3

INDEX TO EXHIBITS

Exhibit
Number	Description
99	Press release dated April 30, 2014

4

EX-99

 

	Exhibit 99
Press Release

Contact:	Claire M. Gulmi
	Executive Vice President and
	Chief Financial Officer
	(615) 665-1283

AMSURG CORP. TO PRESENT AT THE

DEUTSCHE BANK 39^TH ANNUAL HEALTH CARE CONFERENCE

NASHVILLE, Tenn. – (April 30, 2014) – AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Deutsche Bank 39^th Annual Health Care Conference on Wednesday, May 7, 2014, in Boston, Massachusetts.  In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company’s web site starting at 8:40 a.m. Eastern Time / 7:40 a.m. Central Time.  Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.

            The live audio webcast and replay of the presentation will be available on the Company’s website by going to www.amsurg.com  and clicking on Investors.  For the live audio, please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software.  The webcast replay will be available for 30 days.

AmSurg Corp. acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States.  At March 31, 2014, AmSurg owned and operated 242 centers.

- END –